|
WO2019170055A1
|
|
Compounds having cdk4/6 kinase inhibitory activity, pharmaceutical composition thereof and use thereof
|
|
WO2019154329A1
|
|
Compound having bet inhibitory activity and preparation method and use therefor
|
|
WO2019062949A1
|
|
Compound having erk kinase inhibitory activity and use thereof
|
|
CN110229151A
|
|
Indolizine class compound, preparation method and the usage
|
|
CN110229157A
|
|
Pyrimido 5-membered aromatic heterocycle class compound, preparation method and the usage
|
|
MX2019002616A
|
|
Pyrido five-element aromatic ring compound, preparation method therefor and use thereof.
|
|
CN106188038A
|
|
One class has the compound of kinase inhibiting activity, preparation method and purposes
|
|
CN107216312A
|
|
A kind of compound with saltant type IDH inhibitory activity, preparation method and the usage
|
|
BR112017003312A2
|
|
As indazole compound FGFR kinase inhibitor and preparation and application
|
|
CN105218548A
|
|
A kind of novel heterocyclic compounds and preparation method thereof and the purposes as kinase inhibitor
|
|
CN104774209A
|
|
9-allylcamptothecin derivative synthesis method
|
|
CN101443330A
|
|
Heterocycle non-nucleosides compound and preparation method thereof, medicament composition and purpose as antivirus antivirus inhibitor
|
